the uncomplicated course of covid-19 in primary immunodeficiency patients: a report of 14 common variable immunodeficiency patients

Coronavirus disease 2019 (covid-19) affects millions of people worldwide. clinical manifestations range from asymptomatic to severe viral pneumonia. cvid patients with covid-19 infection are not adequately studied. in some studies, cvid patients had higher mortality rates, although other studies showed that cvid patients might have an uncomplicated covid-19 infection. we describe 14 cases of covid-19 infection in iranian cvid patients in this study, including clinical manifestations, laboratory findings, and treatment strategies. there were 29% of patients with mild disease, 43% with moderate disease, and 29% with severe disease in this study. a critical case and a death occurred in none of our patients. there were six cases of infection more than two weeks after receiving the second dose of sinopharm bibp covid-19 vaccine; all had mild to moderate disease. among these patients, remdesivir was the most frequently prescribed medication. according to this study, most of our patients presented with an uncomplicated disease course.